Bioinformatics Innovation at PlusLLaLN

Applying AI and computational biology to revolutionize genetic research and healthcare outcomes.

Scroll to Details
🧬

Project Overview

Our bioinformatics initiative combines machine learning with genetic data analysis to advance personalized medicine, drug discovery, and genomic research. We're developing novel tools that help scientists analyze DNA patterns faster and more accurately.

Key Achievements

🧬

Genomic Analysis

Automated sequencing tools reduce analysis time by 70% compared to traditional methods.

🧬

Drug Discovery

Predicted novel targets for cancer therapies with 92% success in validation trials.

🧬

Personalized Medicine

AI models enable tailored treatment plans based on individual patient genetic profiles.

Methodology

1. Data Collection
Collaborated with 18 global research labs to gather genomic, proteomic, and phenotypic datasets.
2. AI Modeling
Developed transformer-based models for gene prediction and mutation analysis using deep learning techniques.
3. Validation
Validated findings through clinical trials with leading hospitals in partnership with biopharma companies.

Industry Partners

Modern Health
Genome CoE
Pharma Lite
Cell Tech

Want to see more?

Download the full technical report and see how we're transforming genetic research with AI.

Download Report